Well… company is basically worthless.
gone from having phase 2 trials running to 2 very early pre-clinical assets.
assume Mautner will resign and have to take responsibility for the failed strategy. I hope GK will find a buyer for his shares at whatever price these fall to and also sell out so the company can clean slate.
I plan to just hold and check in few years from now.
Ann: Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59022 | 8.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 118764 | 1 |
View Market Depth
| Last trade - 11.08am 04/06/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable